✦ LIBER ✦

Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ

✍ Scribed by R. Barry Hird; Alfred Chang; Vincent Cimmino; Kathleen Diehl; Michael Sabel; Celina Kleer; Mark Helvie; Anne Schott; Jennifer Young; Daniel Hayes; Lisa Newman

Book ID: 102106809
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 82 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21873

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of p21Waf1, p27Kip1 and cycli

Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status

✍ Young Lyun Oh; Jong Sun Choi; Sang-Yong Song; Young Hyeh Ko; Boo-Kyung Han; Seok 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

HER2 protein overexpression in estrogen

HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy

✍ Collins, Laura C; Schnitt, Stuart J 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 247 KB

Impact of race and ethnicity on features

Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast

✍ Adele A. Bailes; Henry M. Kuerer; Sara A. Lari; Lovell A. Jones; Abenaa M. Brews 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 778 KB

Comments on p53 protein expression, cell

Comments on p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the Breast Rudas et al., Eur.E. Cancer 1997, 33, No. 1, 39–44

✍ F.C. Schmitt 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 124 KB